Andrea Volkamer studied bioinformatics at Saarland University, followed by a one-year research stay at Purdue University (USA). After her doctorate at the University of Hamburg with a focus on computer-aided drug design, she worked at the BioMedX Innovation Center Heidelberg as a PostDoc on methods for developing selective kinase inhibitors. From 2016-2022, she led a research group for structural bioinformatics and in silico toxicology at the Institute of Physiology at Charité Universitätsmedizin Berlin as a junior professor. Since Aug. 2022, Andrea Volkamer has held a professorship at Saarland University in the field of "Data Driven Drug Design".